2024 ranking of top 10 U.S. biotech and pharmaceutical companies based on total revenue (in billion U.S. dollars)
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you U.S. pharmaceutical industry
Contribution to global pharma
5
- Premium Statistic World pharmaceutical market distribution by submarket 2014-2023
- Premium Statistic World pharmaceutical sales 2020-2023 by region
- Basic Statistic Market share of the leading global pharmaceutical markets 2022
- Premium Statistic Top global pharmaceutical markets: growth rate 2022
- Premium Statistic Top 50 pharmaceutical companies - Rx sales and R&D spending 2022
Overview
6
- Premium Statistic U.S. total medicine spending 2002-2022
- Basic Statistic Leading therapy areas for U.S. drug spending 2020
- Premium Statistic U.S. top prescribed drugs based on sales 2022
- Premium Statistic Top pharma products by prescriptions U.S. 2021
- Premium Statistic Pharmaceutical channel distribution by U.S. spending 2017-2019
- Premium Statistic U.S. biopharmaceutical export volume 2002-2022
Companies
6
- Premium Statistic 2024 list of top U.S. biotech and pharmaceutical companies based on revenue
- Premium Statistic Pharmaceutical corporations by U.S. revenue 2022
- Basic Statistic AbbVie's revenue 2010-2023
- Premium Statistic Pfizer's total revenue 2006-2023
- Premium Statistic Bristol-Myers Squibb's revenue 2006-2023
- Premium Statistic Johnson & Johnson's total sales 2005-2023
Research and development
7
- Basic Statistic Research and development expenditure: U.S. pharmaceutical industry 1995-2022
- Premium Statistic U.S. pharma industry R&D spending as a percent of total revenues 1990-2022
- Basic Statistic Pharmaceuticals: cost of drug development in the U.S. since 1975
- Premium Statistic Number of novel drugs approved annually by CDER 2008-2023
- Premium Statistic Number of orphan designations accepted in the U.S. 2003-2023
- Basic Statistic U.S. sales of new brand medicines 2012-2021
- Basic Statistic R&D expenditure per employee in U.S. sectors 2003-2017
Generics
5
- Basic Statistic Spending change on branded and generic medicines in the U.S. 2014-2021
- Premium Statistic U.S. brand and generic prescription drug spending 2017-2021
- Premium Statistic Branded vs. generic U.S. drug prescriptions dispensed 2005-2021
- Premium Statistic Savings through generic drug usage in the U.S. 2008-2022
- Premium Statistic Sales share at risk of pharmaceuticals due to patent expiries U.S. 2022
Public view on pharma
6
- Premium Statistic Share of U.S. people who had a favorable view of pharmaceutical companies 2021
- Premium Statistic U.S. approval of pharma companies' COVID-19 vaccine development handling 2021
- Premium Statistic Share of U.S. adults who approve pharmaceutical companies' drug price handling 2021
- Basic Statistic Share of people who had a favorable view of Pfizer in U.S. 2021
- Basic Statistic Share of people who had a favorable view of Moderna in U.S. 2021
- Premium Statistic Share of people who had a favorable view of J&J in U.S. 2021
Outlook
4
- Premium Statistic World pharmaceutical sales by region forecast 2027
- Premium Statistic Sales at risk of pharmaceuticals due to patent expiries U.S. 2022
- Basic Statistic Leading U.S. pharmaceutical products by revenue 2026
- Basic Statistic U.S. cannabinoid-based pharmaceuticals market size 2020-2029 projection
Further related statistics
19
- Top pharma and biotech companies by net sales growth in 2022
- Top 10 global pharmaceutical companies by revenue 2022
- Leading global pharmaceutical risers based on share price 2022
- Global leading pharma and biotech companies by total revenue in 2017
- Top pharmaceutical companies' SG&A to revenue rate 2022
- Market cap of select pharma companies with strong pipeline 2017
- Leading global pharmaceutical risers based on market capitalization 2022
- M&A capacities - changes for the global pharma industry 2008-2015
- Total equity of the Ipsen group 2014-2019
- Top global generic pharmaceutical companies, by enterprise value 2016
- Top global generic pharmaceutical companies 2015, by revenue
- Top 10 - pharmaceutical companies based on revenue in 2006
- Business risks at selected pharmaceutical companies 2011
- Lease expenses of selected U.S. pharmaceutical companies 2011 and 2016
- Astellas Pharma's revenue FY 2023, by region
- Mexico: veterinary pharmaceutical laboratories 2018, by type
- Financing pattern of drugs and pharmaceutical industry India 2020, by value
- Relative Nifty price performance GSK India 2009-2018
- Worldwide generic pharmaceutical M&A deal value 2007-2015
Further Content: You might find this interesting as well
Statistics
- Top pharma and biotech companies by net sales growth in 2022
- Top 10 global pharmaceutical companies by revenue 2022
- Leading global pharmaceutical risers based on share price 2022
- Global leading pharma and biotech companies by total revenue in 2017
- Top pharmaceutical companies' SG&A to revenue rate 2022
- Market cap of select pharma companies with strong pipeline 2017
- Leading global pharmaceutical risers based on market capitalization 2022
- M&A capacities - changes for the global pharma industry 2008-2015
- Total equity of the Ipsen group 2014-2019
- Top global generic pharmaceutical companies, by enterprise value 2016
- Top global generic pharmaceutical companies 2015, by revenue
- Top 10 - pharmaceutical companies based on revenue in 2006
- Business risks at selected pharmaceutical companies 2011
- Lease expenses of selected U.S. pharmaceutical companies 2011 and 2016
- Astellas Pharma's revenue FY 2023, by region
- Mexico: veterinary pharmaceutical laboratories 2018, by type
- Financing pattern of drugs and pharmaceutical industry India 2020, by value
- Relative Nifty price performance GSK India 2009-2018
- Worldwide generic pharmaceutical M&A deal value 2007-2015
Financial Times. (February 6, 2024). 2024 ranking of top 10 U.S. biotech and pharmaceutical companies based on total revenue (in billion U.S. dollars) [Graph]. In Statista. Retrieved June 01, 2024, from https://www.statista.com/statistics/257436/top-global-biotech-and-pharmaceutical-companies-based-on-revenue/
Financial Times. "2024 ranking of top 10 U.S. biotech and pharmaceutical companies based on total revenue (in billion U.S. dollars)." Chart. February 6, 2024. Statista. Accessed June 01, 2024. https://www.statista.com/statistics/257436/top-global-biotech-and-pharmaceutical-companies-based-on-revenue/
Financial Times. (2024). 2024 ranking of top 10 U.S. biotech and pharmaceutical companies based on total revenue (in billion U.S. dollars). Statista. Statista Inc.. Accessed: June 01, 2024. https://www.statista.com/statistics/257436/top-global-biotech-and-pharmaceutical-companies-based-on-revenue/
Financial Times. "2024 Ranking of Top 10 U.S. Biotech and Pharmaceutical Companies Based on Total Revenue (in Billion U.S. Dollars)." Statista, Statista Inc., 6 Feb 2024, https://www.statista.com/statistics/257436/top-global-biotech-and-pharmaceutical-companies-based-on-revenue/
Financial Times, 2024 ranking of top 10 U.S. biotech and pharmaceutical companies based on total revenue (in billion U.S. dollars) Statista, https://www.statista.com/statistics/257436/top-global-biotech-and-pharmaceutical-companies-based-on-revenue/ (last visited June 01, 2024)
2024 ranking of top 10 U.S. biotech and pharmaceutical companies based on total revenue (in billion U.S. dollars) [Graph], Financial Times, February 6, 2024. [Online]. Available: https://www.statista.com/statistics/257436/top-global-biotech-and-pharmaceutical-companies-based-on-revenue/